2010
DOI: 10.1016/j.iccn.2010.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Probiotics and diarrhoea management in enterally tube fed critically ill patients—What is the evidence?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
16
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(19 citation statements)
references
References 59 publications
3
16
0
Order By: Relevance
“…Floch et al [32] reported that for the primary prevention of disease caused by C. difficile in patients treated with antibiotics, probiotics also decrease the incidence of such disease, especially when strains of S. boulardii, and possibly other Lactobacillus, such as GG, are administered. Instead, a recent meta-analysis settled that only four probiotic strains (not including Lactobacillus GG) have been shown to significantly decrease the incidence of diarrhoea induced by C. difficile, such as follows: S. boulardii (2 × 10 10 CFU/day), L. casei DN114001 (probiotic drink twice daily), a mixture of L. acidophilus and Bifidobacterium bifidum (2 × 10 10 CFU/day), and a mixture of L. acidophilus, L. casei, and L. rhamnosus) [33].…”
Section: Saccharomyces Boulardii Lactobacillus Acidophilus Lactobacmentioning
confidence: 99%
See 1 more Smart Citation
“…Floch et al [32] reported that for the primary prevention of disease caused by C. difficile in patients treated with antibiotics, probiotics also decrease the incidence of such disease, especially when strains of S. boulardii, and possibly other Lactobacillus, such as GG, are administered. Instead, a recent meta-analysis settled that only four probiotic strains (not including Lactobacillus GG) have been shown to significantly decrease the incidence of diarrhoea induced by C. difficile, such as follows: S. boulardii (2 × 10 10 CFU/day), L. casei DN114001 (probiotic drink twice daily), a mixture of L. acidophilus and Bifidobacterium bifidum (2 × 10 10 CFU/day), and a mixture of L. acidophilus, L. casei, and L. rhamnosus) [33].…”
Section: Saccharomyces Boulardii Lactobacillus Acidophilus Lactobacmentioning
confidence: 99%
“…However, in additional research was described lower improvements in the reduction of disease in association with conventional treatment in patients with UC, and minor to moderate contribution, with the use of probiotic VSL#3, Escherichia coli Nissle, Lactobacillus GG, or milk fermented with bifidobacteria and/or lactobacilli (whether or not compared to placebo or other treatments, such as mesalazine) [38]. In trials with probiotics on remission induction or maintenance in Crohn's disease (using several strains such as Lactobacillus GG, VSL3, L. johnsonii LA1, Escherichia coli Nissle 1917, S. boulardii) have been reported less satisfactory results than in UC [32].…”
Section: Probiotics In In Diseases Of the Gastrointestinal Apparatusmentioning
confidence: 99%
“…Dasopoulou et al [50] published a study similar to those of Indrio et al [51,52] Vandeplas et al [54] using the same sample size than above assessed the impact of this combination among formula, fermented formula and prebiotic on colic. After 4 weeks of treatment the research group demonstrated a reduced overall incidence of infantile colic in group 3 GOS/FOS +50% FERM, better than in group 1 and 4, suggesting a dose response for the fermented formula.…”
Section: Studies Assessing the Effects Of Combinations Of Prebiotic Imentioning
confidence: 99%
“…Various therapeutic effects have been ascribed to probiotics like Lactobacillus reuteri and other probiotics including correction of functional dysmotility, moderation of inflammation-associated disease states and hypertension [73][74][75][76][77].…”
Section: Probioticsmentioning
confidence: 99%